BMS Investing $400 Million in Dublin Sterile Drug Expansion

GALWAY, IRELAND--March 19, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Bristol-Myers Squibb Company (BMS) (NYSE:BMY) (New York, New York) has opted to build its first European sterile drug product (SDP) facility in Dublin, Ireland.

Within this article: Details $400 million investment in Dublin operations to build a sterile drug facility, timeline, products, existing operations